When you imagine working with a computer, you likely think of keyboards, clicks, or typing on your phone. But Science Corporation CEO Max Hodak has a different vision. His company is leading the first U.S. human trials for a biohybrid brain-computer interface, promising a future where interfaces adapt to us, not the other way around.

At TechCrunch Disrupt 2026, Hodak will present his case for a post-screen future, where brain-computer interactions transform how we engage with machines. With 10,000+ tech leaders, founders, and investors in attendance, this could be the moment the screen era truly ends.

Hodak’s journey began with programming at six, and has seen him co-founding companies like Transcriptic, Neuralink, and Science Corporation. His latest venture, Science Corporation, has already restored eyesight in people with severe vision loss, and Hodak envisions applications that could heal brain cells, warn of seizures, and even treat severe conditions like Parkinson’s.

Secure your ticket today and hear Hodak’s ambitious plans for the future of technology. This is your chance to learn how the interface between people and machines is about to change, and the many ways that could impact your life.